4th Quarter - Report

INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA

Firm
Client
Income
—
Expenses
$136,124
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; physician payments; Medicaid and Medicare, including Medicare Prescription Drug Coverage; Average Sales Price; Competitive Acquisition Program; infection control; antimicrobial stewardship; and Healthcare Reform.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate
JASON SCULL Program Officer for Clinical Affairs

Contacted: SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; and support for evidence-based decision making.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); SENATE; U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Infectious diseases; drug and vaccine research and development; antimicrobial resistance; antimicrobial stewardship; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues; Ryan White reauthorization; PAMTA H.R. 1549/S.619; Strategies to Address Antimicrobial Resistance (STAAR) Act H.R. 2400.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate

Contacted: Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1549 (111th), S. 619 (111th), H.R. 2400 (111th)

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Office of the Biomedical Advanced Research and Development Authority (BARDA), Centers for Disease Control and Prevention, National Institutes of Health, Health Resources & Services Administration, Food & Drug Administration and global programs for various infectious diseases related issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Affiliated organisations

OrganisationLocation
HIV MEDICINE ASSOCIATION Arlington, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.